IMPROVING UTILIZATION OF SGLT-2 INHIBITORS IN VETERANS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE IN A VA PRIMARY CARE CLINIC

被引:0
|
作者
Anderson, Rachel [1 ]
Day, Jonathan [1 ]
de la Serna, Solanus [1 ]
Hines, Mackenzie [1 ]
Prathivadhi-Bhayankaram, Sruti [1 ]
Salomone, Joseph [1 ]
Vather, Naomi [1 ]
Zandvakili, Arya [1 ]
Brettell, Leslie [1 ]
Johnson, Krista M. [2 ]
Hupp, Derek [3 ]
机构
[1] Univ Iowa Hosp & Clin, Internal Med, Iowa City, IA USA
[2] Univ Iowa, Internal Med, Iowa City, IA USA
[3] Iowa City VA Med Ctr, Internal Med, Iowa City, IA USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:S695 / S695
页数:1
相关论文
共 50 条
  • [31] Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care
    Lou Arnal, L. M.
    Campos Gutierrez, B.
    Cuberes Izquierdo, M.
    Gracia Garcia, O.
    Turon Alcaine, J. M.
    Bielsa Garcia, S.
    Gimeno Orna, J. A.
    Boned Juliani, B.
    Sanjuan Hernandez-French, A.
    NEFROLOGIA, 2010, 30 (05): : 552 - 556
  • [32] Treatment of Type 2 Diabetes Mellitus in Advanced Chronic Kidney Disease for the Primary Care Physician
    Mallappallil, Mary
    Sasidharan, Sandeep
    Sabu, Jacob
    John, Sabu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [33] The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone
    Li, Yan-Rong
    Liu, Chi-Hung
    Sun, Wei-Chiao
    Fan, Pei-Yi
    Liu, Feng-Hsuan
    Chen, Tien-Hsing
    Wu, Victor Chien-Chia
    Lin, Chihung
    Hsiao, Ching-Chung
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (09):
  • [34] The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure
    Riggs, Kayla
    Ali, Hiba
    Taegtmeyer, Heinrich
    Gutierrez, Absalon D.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (07) : 292 - 297
  • [35] The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitors
    Weir, Matthew R.
    POSTGRADUATE MEDICINE, 2016, 128 (03) : 290 - 298
  • [36] Role of the Kidney in Glucose Homeostasis: Implications for SGLT-2 Inhibition in the Treatment of Type 2 Diabetes Mellitus
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (02): : S3 - S5
  • [37] New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
    Claire C. J. Dekkers
    Ron T. Gansevoort
    Hiddo J. L. Heerspink
    Current Diabetes Reports, 2018, 18
  • [38] New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
    Dekkers, Claire C. J.
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    CURRENT DIABETES REPORTS, 2018, 18 (05)
  • [39] Diabetes mellitus: Does SGLT-2 Inhibitors increase the Risk of Amputation?
    Gallwitz, Baptist
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (06) : 366 - +
  • [40] SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
    Raj, Henith
    Durgia, Harsh
    Palui, Rajan
    Kamalanathan, Sadishkumar
    Selvarajan, Sandhiya
    Kar, Sitanshu Sekhar
    Sahoo, Jayaprakash
    WORLD JOURNAL OF DIABETES, 2019, 10 (02) : 114 - 132